Filing Flows › GoodRx Holdings (GDRX) › How it makes money
How GoodRx Holdings (GDRX) makes money
GoodRx Holdings (GDRX) made $200M of revenue in the second quarter 2026 (Q2 2026), -1% from a year earlier. Prescription transactions revenue brought in $106M (53%); Pharma Direct revenue brought in $61.6M (31%); Subscription revenue brought in $28.5M (14%). Of every dollar of revenue, 12¢ was left as operating profit, 4¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Prescription transactions revenue | $106M | 53.1% | -6% | -26% |
| Pharma Direct revenue | $61.6M | 30.8% | +18% | +76% |
| Subscription revenue | $28.5M | 14.2% | +17% | +39% |
| Other revenue | $3.9M | 1.9% | +5% | -15% |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $200M | 100.0% |
| Operating profit | $23.6M | 11.8% |
| Income tax | $6.9M | 3.5% |
| Net earnings | $8.5M | 4.3% |
| Operating cash flow | $80.8M | 40.3% |
| Free cash flow | $80.5M | 40.2% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $200M | -1% |
| Q1 2026 | $194M | -4% |
| Q4 2025 | $195M | -2% |
| Q3 2025 | $196M | +0.4% |
| Q2 2025 | $203M | +1% |
| Q1 2025 | $203M | +3% |
| Q4 2024 | $199M | +1% |
From GoodRx Holdings' 10-Q filed Aug 5, 2026 (on EDGAR).
Questions
How does GoodRx Holdings make money?
GoodRx Holdings (GDRX) made $200M of revenue in the second quarter 2026 (Q2 2026), -1% from a year earlier. Prescription transactions revenue brought in $106M (53%); Pharma Direct revenue brought in $61.6M (31%); Subscription revenue brought in $28.5M (14%). Of every dollar of revenue, 12¢ was left as operating profit, 4¢ was left as net earnings.
What is GoodRx Holdings' biggest business?
Prescription transactions revenue: $106M in the second quarter 2026, 53% of revenue, -26% from a year earlier.
What is GoodRx Holdings' profit margin?
Net earnings were $8.5M, 4.3% of revenue, in the second quarter 2026; the operating margin was 11.8%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.